CardiologyOnline.net

Cardiology Xagena

Xagena Mappa
Medical Meeting
Onco News
Gastrobase.it

Search results for "Efient"

Prasugrel ( Efient, Effient ), a new antiplatelet agent that provides higher levels of platelet inhibition than current standard therapies, could provide more consistent protection from ischemic event ...


Prasugrel ( Efient, Effient ), a new antiplatelet agent that provides higher levels of platelet inhibition than current standard therapies, could provide more consistent protection from ischemic eve ...


Treatment with Prasugrel ( Efient, Effient ) and Acetylsalicylic acid ( Aspirin ) improves outcomes compared with Clopidogrel ( Plavix ) and Acetylsalicylic acid for patients with acute coronary syndr ...


American Heart Association ( AHA ) and American College of Cardiology ( ACC ) have updated the guideline for the management of patients with non–ST-elevation acute coronary syndromes ( NSTE-ACS ). T ...


Dual antiplatelet therapy is recommended after coronary stenting to prevent thrombotic complications, yet the benefits and risks of treatment beyond 1 year are uncertain. Patients were enrolled aft ...


Morphine is recommended in patients with ST-segment-elevation myocardial infarction, including those undergoing primary percutaneous coronary intervention ( PCI ). Suboptimal antiplatelet effect durin ...


The landmark Dual Antiplatelet Therapy ( DAPT ) trial revealed an impressive reduction of stent thrombosis and myocardial infarction after prolonged 30-month DAPT compared to the conventional 12-month ...


When considering antiplatelet therapy for acute coronary syndrome ( ACS ), it is essential to balance benefits ( less thrombotic / ischaemic events ) versus bleeding risks related to intense platelet ...